NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-104.23%
↑ 30% vs avg
Percentile
P15
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-147.94%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -104.23% |
| Q3 2025 | -4.25% |
| Q2 2025 | -2506.70% |
| Q1 2025 | -126.99% |
| Q4 2024 | 107.80% |
| Q3 2024 | -12.98% |
| Q2 2024 | -8.52% |
| Q1 2024 | 42.90% |
| Q4 2023 | -31.23% |
| Q3 2023 | 1.27% |
| Q2 2023 | 17.21% |
| Q1 2023 | -1.70% |
| Q4 2022 | -443.11% |
| Q3 2022 | 138.60% |
| Q2 2022 | 18.16% |
| Q1 2022 | -20.25% |
| Q4 2021 | -32.02% |
| Q3 2021 | 11.36% |
| Q2 2021 | 3.80% |
| Q1 2021 | -24.98% |
| Q4 2020 | -798.37% |
| Q3 2020 | 122.30% |
| Q2 2020 | 2.19% |
| Q1 2020 | -2.07% |
| Q4 2019 | -7.17% |
| Q3 2019 | 31.84% |
| Q2 2019 | 10.65% |
| Q1 2019 | -168.21% |
| Q4 2018 | 25.12% |
| Q3 2018 | -32.80% |
| Q2 2018 | -19.00% |
| Q1 2018 | 1.19% |
| Q4 2017 | -0.32% |
| Q3 2017 | -6.09% |
| Q2 2017 | -60.22% |
| Q1 2017 | -99.63% |
| Q4 2016 | -2241.08% |
| Q3 2016 | 200.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 100.00% |